scholarly journals Evaluating Human Papillomavirus Vaccination Programs

2004 ◽  
Vol 10 (11) ◽  
pp. 1915-1923 ◽  
Author(s):  
Al V. Taira ◽  
Christopher P. Neukermans ◽  
Gillian D. Sanders
2016 ◽  
Vol 22 (10) ◽  
pp. 1732-1740 ◽  
Author(s):  
David Mesher ◽  
Kate Soldan ◽  
Matti Lehtinen ◽  
Simon Beddows ◽  
Marc Brisson ◽  
...  

2015 ◽  
Vol 85 (5) ◽  
pp. 289-298 ◽  
Author(s):  
Jessica A. Nodulman ◽  
Randall Starling ◽  
Alberta S. Kong ◽  
David B. Buller ◽  
Cosette M. Wheeler ◽  
...  

2009 ◽  
Vol 19 (9) ◽  
pp. 1610-1613 ◽  
Author(s):  
Katharine Astbury ◽  
Michael J. Turner

Cervical cancer remains a major cause of morbidity and mortality for women worldwide. Although the introduction of comprehensive screening programs has reduced the disease incidence in developed countries, it remains a major problem in the developing world. The recent licensing of 2 vaccines against human papillomavirus (HPV) type 16 and HPV-18, the viruses responsible for 70% of cervical cancer cases, offers the hope of disease prevention. In this article, we review the role of HPV in the etiology of cervical cancer and the evidence to support the introduction of vaccination programs in young women and discus the potential obstacles to widespread vaccination. In addition, we discuss the issues that remain to be elucidated, including the potential need for booster doses of the vaccine and the role of concomitant vaccination in men.


Vaccine ◽  
2009 ◽  
Vol 27 (37) ◽  
pp. 5133-5141 ◽  
Author(s):  
Ingrid Zechmeister ◽  
Birgitte Freiesleben de Blasio ◽  
Geoff Garnett ◽  
Aileen Rae Neilson ◽  
Uwe Siebert

2013 ◽  
Vol 53 (1) ◽  
pp. 6-13 ◽  
Author(s):  
Nathalie Broutet ◽  
Nicholas Lehnertz ◽  
Garrett Mehl ◽  
Alma Virginia Camacho ◽  
Paul Bloem ◽  
...  

Vaccine ◽  
2021 ◽  
Author(s):  
Danielle Engel ◽  
Abra Dela Jeanne Afeli ◽  
Christopher Morgan ◽  
Willibald Zeck ◽  
David A Ross ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document